6-Sialyllactose Sodium Salt – HMO for Gut and Immune Health

What is 6-Sialyllactose Sodium Salt?

6-Sialyllactose sodium salt (abbreviated 6-SL-Na) is the sodium salt-stabilized form of 6-sialyllactose, a naturally occurring human milk oligosaccharide (HMO). HMOs are complex carbohydrate molecules found in great diversity in human breast milk, where they play a central role in early childhood development. The molecule consists of the disaccharide lactose with a sialic acid (N-acetylneuraminic acid) attached via an alpha-2,6-glycosidic bond. The sodium salt form enhances solubility and stability, making it the preferred form for use in foods, infant formulas, and dietary supplements.

Biological Functions and Mechanism of Action

6-Sialyllactose sodium salt exerts its effects through several biological mechanisms that are particularly relevant to infant gut health and immune function:

• Prebiotic effect: 6-SL-Na selectively promotes the growth of beneficial gut bacteria such as Bifidobacterium species, thereby supporting the establishment of a healthy gut microbiota.
• Anti-infective properties: Acting as a receptor analogue, the molecule competes with cell surface receptors for the binding of pathogens such as viruses and bacteria, thereby neutralizing them before they can adhere to the intestinal mucosa.
• Immune modulation: 6-SL-Na influences the maturation and regulation of the infant immune system by modulating immune cell activity and dampening inflammatory responses.
• Support of brain development: Sialic acid, the functional building block of the molecule, is a key component of brain gangliosides and is considered an important nutrient for cognitive development in infants.

Sources and Occurrence

6-Sialyllactose is naturally present in human breast milk, where it is one of the more abundant HMOs. Its concentration varies depending on the stage of lactation and individual factors. In animal milk (e.g., cow milk), it is present only in trace amounts. For industrial applications, 6-sialyllactose sodium salt is produced biotechnologically, typically through fermentation processes using genetically engineered microorganisms.

Medical and Nutritional Applications

Infant Formula and Supplements

6-Sialyllactose sodium salt is increasingly used as an ingredient in infant and follow-on formula to better mimic the composition of human breast milk. The goal is to bring formula-fed infants closer to breastfed infants in terms of gut health and immune development. It is also found in dietary supplements aimed at supporting gut health in adults.

Therapeutic Research

Ongoing research is investigating the potential of 6-SL-Na and other HMOs in the prevention and treatment of:

• Gastrointestinal infections
• Inflammatory bowel disease
• Allergic conditions and atopy
• Necrotizing enterocolitis (NEC) in newborns

Safety and Tolerability

6-Sialyllactose sodium salt is generally considered safe and well tolerated. The European Food Safety Authority (EFSA) has evaluated and approved several HMOs, including sialylated oligosaccharides, for use in foods. Adverse effects at recommended doses are rare; at higher doses, mild gastrointestinal symptoms such as bloating or loose stools may occur. Individuals with lactose intolerance should note that the molecule is structurally related to lactose, although it does not behave like free lactose in the body. Individual tolerability testing may nonetheless be advisable.

Recommended Intake and Dosage

Uniform official dosage recommendations for 6-sialyllactose sodium salt as a supplement do not yet exist. In clinical studies and approved infant products, amounts in the range of 0.1 to 1.0 g per day are typically used. The optimal dose depends on the intended application, age, and health status of the individual.

References

1. EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA): Safety of 2'-fucosyllactose and lacto-N-neotetraose as novel food ingredients. EFSA Journal, 2019.
2. Bode L.: Human milk oligosaccharides: every baby needs a sugar mama. Glycobiology, 2012; 22(9): 1147-1162. PubMed PMID: 22513036.
3. Donovan SM, Comstock SS.: Human Milk Oligosaccharides Influence Neonatal Mucosal and Systemic Immunity. Annals of Nutrition and Metabolism, 2016; 69(Suppl 2): 42-51. PubMed PMID: 27855420.